34 New Ultra-Effective Surface Sanitiser Gives Workplaces a Clean Bill of Health


With the UK Government continuing to ease lockdown measures, increasing numbers of companies and commercial premises are opening for business after a hiatus due to COVID-19. To help protect the health of those making their way back to the offi ce, factory, shop, pub, gym or any other place of work, a new ultra-effective surface sanitiser - Hi-KLEEN - is being introduced by Hi-line Industries. Spraying a single coating of HI-KLEEN on to surfaces such as doors, handles, handrails, chairs and desks will not only kill coronavirus, it will provide protection against further contamination for up to fi ve hours.


Hi-KLEEN has been specially formulated to kill and inhibit both bacteria and viruses (including enveloped viruses such as coronavirus) on hard or soft surfaces subject to frequent contact. Simply spray at a distance of approximately 10–20 cm from the surface to be treated for effective protection. This odour-free, clear product is ideal for offi ces, factories (including food plants), conference centres, sports clubs, hospitals, health centres, educational facilities, care homes, entertainment/hospitality venues (including restaurants and pubs), and even transport.


Notably, active biocides present in the formulation provide longer-lasting protection than alcohol-based preparations. Hi-line’s new surface sanitiser does not stain, is non-corrosive and will give a streak and smear-free fi nish to most polished surfaces, including glass and stainless steel. The product is safe to use and alcohol-free, meaning that there is no drying or irritation to the skin.


To provide proof of effi cacy in the control of harmful micro-organisms, HI-KLEEN has been tested to BS EN 1276, which is the European standard for the bactericidal activity of chemical disinfectants. In order to meet the standard, products are tested by an independent laboratory and must kill 99.999% of bacteria within 5 minutes.


Composed of organic, non-chlorinated solvents, HI-KLEEN is offered by Hi-line Industries in both 500ml aerosols and disposable 17kg canisters. The latter is particularly useful for those looking to sanitise entire rooms, providing a typical coverage of 750 square metres. Canisters are connected by either a 3.5 or 5.5 metre hose to a spray gun, delivering an easy-to-use, self-contained, time-saving spraying system that requires minimal set-up.


Any business owners or managers worried about controlling the spread of COVID-19 as the country returns to work can rely on HI-KLEEN to keep surfaces and rooms free of harmful contamination, in turn protecting the health of staff and visitors alike.


More information online: ilmt.co/PL/W36v 52607pr@reply-direct.com


Working Together to Help Fight COVID-19


Haier Biomedical UK is doing its upmost to support healthcare customers and the wider scientifi c community in the fi ght against the coronavirus. It is working closely with its manufacturing facility, supply partners, logistics companies and distributors to deliver the right COVID-19 appropriate product resources and support.


The new 75,000 m2 , purpose-built manufacturing facility has been working 24/7 to provide equipment to support customers


around the globe. Like many of its sister companies within the Haier Group, Haier Biomedical has worked tirelessly and in solidarity with each other and the wider community.


From materials and equipment assistance to PPE and personnel aid, Haier has the knowledge, team and complete cold chain equipment and solutions required to deal with the needs to overcome this pandemic: Class 2 safety cabinets and laminar fl ow; ULT freezers (-86°C); Biomedical freezers (-25°C /-30°C /-40°C /-60°C); Pharmacy refrigeration; Sample Transportation Box; Vaccine and Blood Cold Chain; Laboratory including spark free refrigeration; LN2 More information online: ilmt.co/PL/Vy2y


storage containers and biobanks; Blood bank refrigerators; Wireless monitoring; CO2


incubators. 52279pr@reply-direct.com


Powder Dosing Technology Recognised with the Queen’s Award 2020 for Enterprise in Innovation


3P is delighted to have been awarded with the Queen’s Award for Enterprise in Innovation, in recognition of their Fill2Weight powder micro-dosing technology. Fill2Weight was developed 12 years ago after 3P engineers identifi ed challenges in the fi eld of micro-dosing and fi lling of powders for inhalers, that could be overcome with the application of technologies in a new and novel way. The Queen’s Awards have recognised the technology as a great example of innovation, where several different technologies have been combined into one highly effective and versatile solution.


Now used for multiple pharmaceutical applications, Fill2Weight precisely fi lls a wide range of pharmaceutical containers, including capsules, vials, inhalers, syringes, cartridges, blisters and other special containers.


A major challenge Fill2Weight addresses is getting challenging powders to fl ow so that very small (down to 1mg) and precise doses can be created. This is essential for high-potency drugs, where inaccurate dosing poses risks to patient safety. Its gravimetric system weighs and verifi es every dose. Any doses outside the limits are rejected.


As well as excelling in accuracy, Fill2Weight is the fastest gravimetric dosing system on the market. Fill2Weight’s ability to handle challenging powders helps reduce drug development lead-times by enabling pharma companies to avoid or reduce the need for costly and time consuming ‘formulation for fi lling’ development work. This means customers can achieve ‘fi rst-in-human’ milestones faster, with potential for new drug launch in shorter time-frames.


Fill2Weight is a fl exible and scalable system, ensuring early-stage manufacturing processes can also be used for commercial production. Its narrow design allows for multiple modules to be installed side-by- side, creating a multi-lane solution for higher volume production.


Another challenge 3P addressed was to ensure the technology could accommodate changing powder properties throughout a batch. Conventional fi lling systems cannot do this, affecting accuracy. Fill2Weight’s intelligent software algorithms automatically detect changing properties and modify dose settings to suit.


Fill2Weight’s technology requires as little as 2-3 grams for doses to be created for administration to patients or for other development tests, minimising the amount of drug product required. Unused powder can be recovered, meaning zero waste.


More information online: ilmt.co/PL/0gM0 52278pr@reply-direct.com


Good Laboratory Practices Software Upgrade Announced Biotage AB is pleased to announce the launch of a Good Laboratory Practices (GLP) software upgrade for Biotage®


Extrahera™, their fl agship automated sample preparation instrument for Supported


Liquid Extraction (SLE), Solid Phase Extraction (SPE), Phospholipid Depletion (PLD) and Protein Precipitation (PPT). Biotage customers can now harness the system’s advanced automation tools with the Good Laboratory Practices required by today’s modern laboratories. GLP has evolved from a variety of regulatory bodies, such as the OECD and FDA, and aim to harmonise rules and practices for non-clinical studies, applicable for both public and private organisations. These polices are in place to ensure the quality and validity of data produced have met a standard criteria, ensuring the safety of the study. In essence, GLP is about organising and recording how the study was planned, administered, monitored, and documented.


The new GLP software helps laboratory managers to administer the operation of the system, defi ning users and their different roles, this in turn assists data security through password protection and restricted access levels. The software also enables the system to be networked, opening up options for data handling across a network and management of the system remotely. Finally, the new software creates a detailed audit trail, documenting all activities, including user credentials and reasons for making any method changes.


Biotage has also added a number of non-GLP benefi ts to the software including single sample processing, dual mode extraction and barcode management. “Since its introduction in 2015, the Biotage® Extrahera™ has transformed automated sample preparation with its precision engineering, easy to use software and fl exible formats; now, with the new GLP software package, users can combine the utility of advanced laboratory automation with the organisational features used under GLP,” said Dr Dan Menasco, Global Technical Product Manager, Analytical, Biotage.


More information online: ilmt.co/PL/emgk 51492pr@reply-direct.com


INTERNATIONAL LABMATE - JULY 2020


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52